Alnylam Pharmaceuticals
ALNY
#567
Rank
โ‚น3.110 T
Marketcap
โ‚น24,132
Share price
-2.22%
Change (1 day)
77.35%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company